Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Moorthy, V.
Right arrow Articles by Hill, A. V S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moorthy, V.
Right arrow Articles by Hill, A. V S
Related Collections
Right arrow Immunology
Right arrow Infectious Diseases
Right arrow Drugs
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 62:59-72 (2002)
© 2002 The British Council

Malaria vaccines

Vasee Moorthy and Adrian V S Hill

Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
MRC Laboratories, Fajara, The Gambia

Malaria kills one child in Africa every 30 s. After summarising the burden of malaria, the life-cycle of this parasite in humans and female Anopheles mosquitoes is outlined. Important differences between natural immunity and that induced by current candidate vaccines are discussed. In the main part of the review, the recent rapid expansion in evaluation of candidate malaria vaccines in clinical trials across the world is discussed. Subunit vaccine technologies are progressing rapidly with new delivery systems, vectors and antigens under evaluation as well as new polyepitope approaches. Combination vaccination regimens, improved adjuvants and genetic engineering of antigens are all improving the immunogenicity of candidate vaccines. We also discuss particular difficulties in vaccination against malaria, the conduct of field trials of malaria vaccines in non-industrialised countries and the need for even greater co-operation between researchers. Finally, the important concept of iterative vaccine development is raised and the prospects for effective malaria vaccination are discussed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
A. M. MOORMANN, C. C. JOHN, P. O. SUMBA, D. TISCH, P. EMBURY, and J. W. KAZURA
STABILITY OF INTERFERON-{gamma} AND INTERLEUKIN-10 RESPONSES TO PLASMODIUM FALCIPARUM LIVER STAGE ANTIGEN-1 AND THROMBOSPONDIN-RELATED ADHESIVE PROTEIN IN RESIDENTS OF A MALARIA HOLOENDEMIC AREA
Am J Trop Med Hyg, April 1, 2006; 74(4): 585 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
I.-K. YOON, E. ANGOV, D. LARSON, D. G. HEPPNER, J. F. CUMMINGS, and V. A. STEWART
CHARACTERIZATION OF A HUMAN REFERENCE STANDARD FOR ANTIBODY TO PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN 142
Am J Trop Med Hyg, June 1, 2005; 72(6): 714 - 718.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
S. Mahanty, A. Saul, and L. H. Miller
Progress in the development of recombinant and synthetic blood-stage malaria vaccines
J. Exp. Biol., November 1, 2003; 206(21): 3781 - 3788.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
D. L. Doolan, J. C. Aguiar, W. R. Weiss, A. Sette, P. L. Felgner, D. P. Regis, P. Quinones-Casas, J. R. Yates III, P. L. Blair, T. L. Richie, et al.
Utilization of genomic sequence information to develop malaria vaccines
J. Exp. Biol., November 1, 2003; 206(21): 3789 - 3802.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
B. C. Urban and D. J. Roberts
Inhibition of T Cell Function During Malaria: Implications for Immunology and Vaccinology
J. Exp. Med., January 20, 2003; 197(2): 137 - 141.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.